For instance, late endosomal and lysosomal pathologies were observed in monogenic iPSCs derived from AD patients carrying APP or PSEN1 mutations [8] and early endosome defects were demonstrated in isogenic APP and PSEN1 mutant iPSCs generated by CRISPR/Cas9 knock-in [9]. The gene discussed is APP; the disease is Alzheimer disease.